Cummings Harold G III
Known title: Staff VP,TreasurerCIK: 0001770294
Cummings Harold G III's purchase track record
Cummings Harold G III has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/15/2022 | SON | $124K | +4.9% | +17.4% | -3.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SON | ▲ Buy | Grant | 555 | $32K | 2/18/2022 | View on chart |
| SON | ▼ Sell | Tax Withholding | 204 | $12K | 2/18/2022 | View on chart |
| SON | ▲ Buy | Open Market | 2,200 | $124K | 2/15/2022 | View on chart |
| SON | ▲ Buy | Option Exercise | 111 | $0 | 2/13/2022 | View on chart |
| SON | ▼ Sell | Tax Withholding | 41 | $2K | 2/13/2022 | View on chart |
| SON | ▲ Buy | Option Exercise | 203 | $0 | 2/12/2022 | View on chart |
| SON | ▼ Sell | Tax Withholding | 75 | $4K | 2/12/2022 | View on chart |
| SON | ▼ Sell | Tax Withholding | 131 | $7K | 2/10/2022 | View on chart |
| SON | ▲ Buy | Option Exercise | 357 | $0 | 2/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS cuts Sonoco price target to $51, maintains Neutral rating
UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.
UBS cuts Sonoco price target to $51, maintains Neutral rating. UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.